Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et...

Por Song, Jinlin, Gao, Wei, Xie, Jipan, Tiwana, Simran
Publicado no Adv Ther (2019)

The Role of Health Economics and Outcomes Research in Health Care Reform in China

Por Liang, Wannian, Xie, Jipan, Fu, Hongpeng, Wu, Eric Q.
Publicado em 2014

Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review

Por Gajria, Kavita, Lu, Mei, Sikirica, Vanja, Greven, Peter, Zhong, Yichen, Qin, Paige, Xie, Jipan
Publicado em 2014

Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison

Por Joseph, Alain, Ayyagari, Rajeev, Xie, Meng, Cai, Sean, Xie, Jipan, Huss, Michael, Sikirica, Vanja
Publicado no Eur Child Adolesc Psychiatry (2017)

A retrospective study evaluating the tolerability and effectiveness of adjunctive antihypertensive drugs in patients with inadequate response to initial treatment

Por Ayyagari, Rajeev, Xie, Jipan, Cheng, David, Wu, Eric Q., Huang, Xing‐Yue, Chen, Stephanie
Publicado no J Clin Hypertens (Greenwich) (2018)

Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel synd...

Por Chen, Kristina S, Xie, Jipan, Tang, Wenxi, Zhao, Jing, Jeppesen, Palle B, Signorovitch, James E
Publicado no Ther Clin Risk Manag (2018)

Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review

Por Sunkureddi, Prashanth, Latremouille-Viau, Dominick, Meiselbach, Mark K., Xie, Jipan, Hur, Peter, Joshi, Reeti
Publicado no Rheumatol Ther (2019)

Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review

Por Joshi, Reeti, Latremouille-Viau, Dominick, Meiselbach, Mark K., Xie, Jipan, Park, Yujin, Sunkureddi, Prashanth
Publicado no Drugs Real World Outcomes (2019)

The Role of Public Health in Promoting Quality Improvement in Care for Stroke and Heart Disease

Por George, Mary G, Matters, Michael D, Xie, Jipan, McGruder, Henraya F, Valderrama, Amy L
Publicado em 2008

Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors

Por Ayyagari, Rajeev, Neary, Maureen, Li, Shang, Rokito, Ariel, Yang, Hongbo, Xie, Jipan, Benson, Al B.
Publicado no Am Health Drug Benefits (2017)

Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure

Por Chen, Kristina, Mu, Fan, Xie, Jipan, Kelkar, Sneha S., Olivier, Clément, Signorovitch, James, Jeppesen, Palle B.
Publicado no JPEN J Parenter Enteral Nutr (2019)

Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity D...

Por Sikirica, Vanja, Erder, M. Haim, Xie, Jipan, Macaulay, Dendy, Diener, Melissa, Hodgkins, Paul, Wu, Eric Q.
Publicado em 2012

Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study

Por Li, Nanxin, Hao, Yanni, Xie, Jipan, Lin, Peggy L., Koo, Valerie, Ohashi, Erika, Wu, Eric Q.
Publicado no Int J Breast Cancer (2015)

Clinical outcomes among HR+/HER2− metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US

Por Xie, Jipan, Hao, Yanni, Li, Nanxin, Lin, Peggy L., Ohashi, Erika, Koo, Valerie, Wu, Eric Q.
Publicado no Exp Hematol Oncol (2015)

Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

Por Song, Jinlin, Ma, Qiufei, Gao, Wei, Cong, Ze, Xie, Jipan, Zimmerman, Zachary, Belton, Laura, Franklin, Janet, Palmer, Stephen
Publicado no Adv Ther (2019)

Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application...

Por Erder, M. Haim, Xie, Jipan, Signorovitch, James E., Chen, Kristina S., Hodgkins, Paul, Lu, Mei, Wu, Eric Q., Sikirica, Vanja
Publicado em 2013

Physician experiences and preferences in the treatment of HR+/HER2− metastatic breast cancer in the United States: a physician survey

Por Lin, Peggy L., Hao, Yanni, Xie, Jipan, Li, Nanxin, Zhong, Yichen, Zhou, Zhou, Signorovitch, James E., Wu, Eric Q.
Publicado no Cancer Med (2015)

Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis

Por Ailawadhi, Sikander, Parikh, Kejal, Abouzaid, Safiya, Zhou, Zhou, Tang, Wenxi, Clancy, Zoe, Cheung, Claudia, Zhou, Zheng-Yi, Xie, Jipan
Publicado no Blood Adv (2019)

Mid-term results and factors affecting outcome of a metal-backed unicompartmental knee design: a case series

Por Seyler, Thorsten M, Mont, Michael A, Lai, Lawrence P, Xie, Jipan, Marker, David R, Zywiel, Michael G, Bonutti, Peter M
Publicado em 2009

Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-...

Por Sikirica, Vanja, Findling, Robert L., Signorovitch, James, Erder, M. Haim, Dammerman, Ryan, Hodgkins, Paul, Lu, Mei, Xie, Jipan, Wu, Eric Q.
Publicado em 2013